Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Integrated Mechanistic Modelling and Analysis of Large-scale Biomedical Data

Project description

Cancer treatment with advanced modelling

Current cancer treatments rely on understanding the intricate signalling processes within cancer cells and their interactions with immune cells. However, existing models focus on limited pathways and use cell line data that poorly represent real cancer tissues. This hampers the identification of effective drug targets. In this context, the ERC-funded INTEGRATE project aims to transform this landscape. By combining mechanistic modelling with machine learning, INTEGRATE will develop scalable computational methods to analyse large-scale biomedical data. Using tools like natural language processing and signal processing, the project will link patient-derived omics and phenotypic data. This approach promises to refine clinical trial designs, advance precision medicine, and pave the way for creating digital twins in cancer research.

Objective

Modern cancer therapeutics target signalling processes within the cancer cells and the interaction of cancer and immune cells. A comprehensive understanding of these signalling processes is therefore essential to identify drug targets, plan clinical trials, and to select suitable drugs, drug combinations and drug dosages for a specific patient. Yet, most of the available mathematical models capture only a small number of molecular species and pathways, thereby ignoring important crosstalk and feedback loops. Furthermore, these models are usually based on experimental data for cell lines, which behave differently from complex cancer tissues.

In INTEGRATE, I will develop computational methods for the full process of data-driven modelling of signalling processes in cancer, ranging from model development to parameterisation all the way to uncertainty analysis. To this end, I will combine methods from the fields of mathematical modelling, machine learning, and signal processing with established approaches in systems biology. The model development will employ natural language processing and an automatic testing framework. For federated model inference, I will develop scalable mini-batch optimisation and marginalisation based uncertainty quantification. To refine models, I will exploit tools from signal processing, such as blind identification of latent variables. I will apply the developed scalable mechanistic modelling approach to integrate large-scale biomedical data for molecular phenotyping studies and clinical trials across sites. This will provide mechanistic models reconciling the available data.

The study will, for the first time, combine mechanistic modelling and machine learning for the integrated analysis of patient-derived omics and phenotypic data. By linking these data sources, INTEGRATE will deepen our understanding of biological signal processing and provide the basis for the development of digital twins.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-COG

See all projects funded under this call

Host institution

RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN
Net EU contribution
€ 1 854 546,00
Address
REGINA PACIS WEG 3
53113 Bonn
Germany
Region
Nordrhein-Westfalen Köln Bonn, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 854 546,00

Beneficiaries (1)